Our Services
Driving Innovation in Drug Discovery and Translational Research
We provide expert consulting to help both users and providers leverage the full potential of cutting-edge spatial biology technologies. Our tailored strategies ensure efficient implementation and deployment, accelerating your research and maximizing impact.
1. Accelerating Spatial Discovery
Tailored strategies for platform selection, assay optimization, CRO guidance, and program management to accelerate drug and biomarker discovery and ensure seamless clinical translation.
Strategic consulting for end-to-end biomarker development that spans target identification, pharmacodynamic assessment, and translational alignment.
Custom integration of immunohistochemistry (IHC), multiplex immunofluorescence (mIF), and spatial transcriptomics to accelerate drug discovery programs.
Expert advice on streamlined assay development, multiplex target selection, and path to clinical application for maximal efficiency.
Guidance on incorporating AI-driven spatial tissue analysis and cloud computing for enhanced productivity.
Identification of leading CROs and program management oversight for high-quality deliverables.
3. Strategic Product Development for Technology Providers
Optimizing product and service offerings to ensure clear application pathways for pharmaceutical and biotechnology clients, increasing market appeal and creating a strong competitive advantage.
Competitive landscape analysis to pinpoint unique value propositions and strategic development opportunities.
Identify paths for clinical utility.
Refinement of products and application strategies that provide clear solutions for drug discovery and development.
Guidance on effective client engagement strategies.
2. Enhancing Quality Management
4. Translational Tissue Solutions
Development of biospecimen procurement and multi-modal strategies that maximize spatial biology applications to accelerate translational breakthroughs.
Identification and qualification of high-quality tissue providers, with guidance on consent and IP protections.
Strategic guidance on integrating paired patient metadata with multi-omics datasets to refine precision medicine strategies.
Solutions for harmonizing clinical metadata for computational integration.
Implementation of GLP-like best practices to achieve greater operational efficiency, data clarity, and regulatory alignment, facilitating a smoother transition into clinical development.
Establishment of technical standards and quality management systems that ensure consistent, reliable, and reproducible non-clinical studies.
Development and implementation of best practices for preclinical labs, including SOPs, equipment qualification, staff training documentation, and data assurance policies.
Incorporation of automated workflows in histology and spatial biology operations for enhanced efficiency and consistency.